GO-LONG

Current fiscal will be a tremendous year for Indian biotech industry. Global recovery has stimulated Indian bitotech industry in 2009-10 and it is apparent from 52% growth in revenue. Among them Cipla can be a good buy both on fundamental and technical front.

Cipla is a prominent Indian pharma company for manufacturing low cost anti-AIDS drugs for HIV patients in developing countries.

Resently Cipla has formed a wholly owned subsidiary 'Cipla Singapore' in Singapore which will aid logistic and distribution of compnay's export business.

Price Information
Open 323.00
High 327.95
Low 322.20
Last Price 325.10
Prev. Close 324.00
Close Price 324.75
Change 1.10
% Change 0.34
Total traded quantity 1282374
Turnover in Rs.Lakhs 4171.82


OI call option @ 340=8750
OI put option @300 =5000

We can expect and anticipate a profit of Rs.10 in coming days and Rs. 40 in a month. I consider Cipla a good buy.

F618

It was the great day to learn as Nifty, in technical terms, showed two classic phenomenon. After steady downfall since 11th  May, the technicals of Nifty showed reversal on 26th May.

but the good days dont last long and Nifty is not an exception. As Niftry retreats people are bit shocked and anticipating a contiuation of downtrend. Now here comes the Technical Analysis into the picture. Check this out..

Traders panicked as Nifty had a red day on 1st June. On technical front Nifty displayed a classical 61.8% retracement. A phenomena that we all read in textbook is appeared in real time.